Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Final Prospectus · 424B4

FOXO TECHNOLOGIES INC.

FOXOOTCEQUITYCurrent

Final Prospectus

Filed Jun 9, 2025Accepted Jun 9, 2025, 5:25 PM EDTCIK 1812360Accession 0001641172-25-014359
Share

Company context

We are a healthcare services and technology company operating in three reportable business segments: (i) Healthcare, (ii) Life Science Services and (iii) Labs, formerly referred to as Labs and Life. These segments further operate in four synergistic divisions, a rural hospital division and a mental and behavioral health division, which make up our Healthcare segment, a biospecimens division, which makes up our Life Science Services segment and an epigenetics diagnostics and interpretation division, which makes up our Labs segment. Our rural hospital division, biospecimens division and epigenetics diagnostics and interpretation division operate through wholly owned subsidiaries, and our behavioral health division operates through a majority-owned subsidiary.

Current securities

Historical securities (5)

Recent company filings

  1. DEF 14C filingAug 24, 2026
  2. PRE 14C filingAug 14, 2026
  3. 10-Q filingAug 14, 2026
  4. Submission of Matters to a Vote of Security HoldersAug 14, 2026
  5. Regulation FD DisclosureJul 29, 2026

As-filed source

Primary evidence